Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases

Li Liu, Rebecca Martin, Christina Chan

    Research output: Contribution to journalArticle

    • 24 Citations

    Abstract

    Astrocytes play a critical role in neurodegenerative diseases, including Alzheimer's disease (AD). Previously, we showed that saturated free fatty acid, palmitic acid (PA), upregulates β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) level and amyloidogenesis in primary rat neurons mediated by astrocytes. However, the molecular mechanisms by which conditioned media from PA-treated astrocytes upregulates BACE1 level in neurons are unknown. This study demonstrates that serine palmitoyltransferase (SPT) in the astrocytes increases ceramide levels, which enhances the release of cytokines that mediate the activation of neural and acidic sphingomyelinase (SMase) in the neurons, to propagate the deleterious effects of PA (i.e., BACE1 upregulation). In support of the relevance of SPT in AD, our laboratory recently measured and found SPT levels to be significantly upregulated in AD brains as compared with controls. Cytokines, namely tumor necrosis factor-α and interleukin-1β, released into the conditioned media of PA-treated astrocytes activate neural and acidic SMase in the neurons. Neutralizing the cytokines in the PA-treated astrocyte conditioned media reduced BACE1 upregulation. However, inhibiting SPT in the astrocytes decreased the levels of both tumor necrosis factor-α and interleukin-1β in the conditioned media, which in turn reduced the SMase activities and BACE1 level in primary neurons. Thus, our results suggest that the activation of the astrocytes by PA is mediated by SPT, and the activated astrocytes increases BACE1 level in the neurons; the latter is mediate by the SMases.

    Original languageEnglish (US)
    Pages (from-to)540-550
    Number of pages11
    JournalNeurobiology of Aging
    Volume34
    Issue number2
    DOIs
    StatePublished - Feb 2013

    Profile

    Serine C-Palmitoyltransferase
    Sphingomyelin Phosphodiesterase
    Palmitates
    Astrocytes
    Neurons
    Palmitic Acid
    Conditioned Culture Medium
    Up-Regulation
    Alzheimer Disease
    Cytokines
    Interleukin-1beta
    Tumor Necrosis Factor-alpha
    Amyloid beta-Protein Precursor
    Ceramides
    Nonesterified Fatty Acids
    Neurodegenerative Diseases
    Fatty Acids
    Brain
    Enzymes

    Keywords

    • Alzheimer's disease
    • Ceramide; TNF-α
    • Fatty acid
    • IL-1β
    • Serine palmitoyltransferase
    • Sphingomyelinase

    ASJC Scopus subject areas

    • Clinical Neurology
    • Neuroscience(all)
    • Aging
    • Developmental Biology
    • Geriatrics and Gerontology

    Cite this

    Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases. / Liu, Li; Martin, Rebecca; Chan, Christina.

    In: Neurobiology of Aging, Vol. 34, No. 2, 02.2013, p. 540-550.

    Research output: Contribution to journalArticle

    Liu, Li; Martin, Rebecca; Chan, Christina / Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases.

    In: Neurobiology of Aging, Vol. 34, No. 2, 02.2013, p. 540-550.

    Research output: Contribution to journalArticle

    @article{6885ad5e2bd94317a39297bfa3e03084,
    title = "Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases",
    abstract = "Astrocytes play a critical role in neurodegenerative diseases, including Alzheimer's disease (AD). Previously, we showed that saturated free fatty acid, palmitic acid (PA), upregulates β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) level and amyloidogenesis in primary rat neurons mediated by astrocytes. However, the molecular mechanisms by which conditioned media from PA-treated astrocytes upregulates BACE1 level in neurons are unknown. This study demonstrates that serine palmitoyltransferase (SPT) in the astrocytes increases ceramide levels, which enhances the release of cytokines that mediate the activation of neural and acidic sphingomyelinase (SMase) in the neurons, to propagate the deleterious effects of PA (i.e., BACE1 upregulation). In support of the relevance of SPT in AD, our laboratory recently measured and found SPT levels to be significantly upregulated in AD brains as compared with controls. Cytokines, namely tumor necrosis factor-α and interleukin-1β, released into the conditioned media of PA-treated astrocytes activate neural and acidic SMase in the neurons. Neutralizing the cytokines in the PA-treated astrocyte conditioned media reduced BACE1 upregulation. However, inhibiting SPT in the astrocytes decreased the levels of both tumor necrosis factor-α and interleukin-1β in the conditioned media, which in turn reduced the SMase activities and BACE1 level in primary neurons. Thus, our results suggest that the activation of the astrocytes by PA is mediated by SPT, and the activated astrocytes increases BACE1 level in the neurons; the latter is mediate by the SMases.",
    keywords = "Alzheimer's disease, Ceramide; TNF-α, Fatty acid, IL-1β, Serine palmitoyltransferase, Sphingomyelinase",
    author = "Li Liu and Rebecca Martin and Christina Chan",
    year = "2013",
    month = "2",
    doi = "10.1016/j.neurobiolaging.2012.05.017",
    volume = "34",
    pages = "540--550",
    journal = "Neurobiology of Aging",
    issn = "0197-4580",
    publisher = "Elsevier Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases

    AU - Liu,Li

    AU - Martin,Rebecca

    AU - Chan,Christina

    PY - 2013/2

    Y1 - 2013/2

    N2 - Astrocytes play a critical role in neurodegenerative diseases, including Alzheimer's disease (AD). Previously, we showed that saturated free fatty acid, palmitic acid (PA), upregulates β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) level and amyloidogenesis in primary rat neurons mediated by astrocytes. However, the molecular mechanisms by which conditioned media from PA-treated astrocytes upregulates BACE1 level in neurons are unknown. This study demonstrates that serine palmitoyltransferase (SPT) in the astrocytes increases ceramide levels, which enhances the release of cytokines that mediate the activation of neural and acidic sphingomyelinase (SMase) in the neurons, to propagate the deleterious effects of PA (i.e., BACE1 upregulation). In support of the relevance of SPT in AD, our laboratory recently measured and found SPT levels to be significantly upregulated in AD brains as compared with controls. Cytokines, namely tumor necrosis factor-α and interleukin-1β, released into the conditioned media of PA-treated astrocytes activate neural and acidic SMase in the neurons. Neutralizing the cytokines in the PA-treated astrocyte conditioned media reduced BACE1 upregulation. However, inhibiting SPT in the astrocytes decreased the levels of both tumor necrosis factor-α and interleukin-1β in the conditioned media, which in turn reduced the SMase activities and BACE1 level in primary neurons. Thus, our results suggest that the activation of the astrocytes by PA is mediated by SPT, and the activated astrocytes increases BACE1 level in the neurons; the latter is mediate by the SMases.

    AB - Astrocytes play a critical role in neurodegenerative diseases, including Alzheimer's disease (AD). Previously, we showed that saturated free fatty acid, palmitic acid (PA), upregulates β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) level and amyloidogenesis in primary rat neurons mediated by astrocytes. However, the molecular mechanisms by which conditioned media from PA-treated astrocytes upregulates BACE1 level in neurons are unknown. This study demonstrates that serine palmitoyltransferase (SPT) in the astrocytes increases ceramide levels, which enhances the release of cytokines that mediate the activation of neural and acidic sphingomyelinase (SMase) in the neurons, to propagate the deleterious effects of PA (i.e., BACE1 upregulation). In support of the relevance of SPT in AD, our laboratory recently measured and found SPT levels to be significantly upregulated in AD brains as compared with controls. Cytokines, namely tumor necrosis factor-α and interleukin-1β, released into the conditioned media of PA-treated astrocytes activate neural and acidic SMase in the neurons. Neutralizing the cytokines in the PA-treated astrocyte conditioned media reduced BACE1 upregulation. However, inhibiting SPT in the astrocytes decreased the levels of both tumor necrosis factor-α and interleukin-1β in the conditioned media, which in turn reduced the SMase activities and BACE1 level in primary neurons. Thus, our results suggest that the activation of the astrocytes by PA is mediated by SPT, and the activated astrocytes increases BACE1 level in the neurons; the latter is mediate by the SMases.

    KW - Alzheimer's disease

    KW - Ceramide; TNF-α

    KW - Fatty acid

    KW - IL-1β

    KW - Serine palmitoyltransferase

    KW - Sphingomyelinase

    UR - http://www.scopus.com/inward/record.url?scp=84869090965&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84869090965&partnerID=8YFLogxK

    U2 - 10.1016/j.neurobiolaging.2012.05.017

    DO - 10.1016/j.neurobiolaging.2012.05.017

    M3 - Article

    VL - 34

    SP - 540

    EP - 550

    JO - Neurobiology of Aging

    T2 - Neurobiology of Aging

    JF - Neurobiology of Aging

    SN - 0197-4580

    IS - 2

    ER -